A1RG34:BVMF
Argenx Se Bdr
R$191.52
arrow_downward
-1.75%(-3.42) 1D
Nov 3, 10:07:34 AM GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for A1RG34...
Open
R$191.52
High
R$191.52
Low
R$191.52
Mkt. cap
55.60B
Avg. vol.
60.00
Volume
61.00
52-wk high
R$213.15
52-wk low
R$143.22
Shares outstanding
62.89M
No. of employees
2K
Open
R$191.52
High
R$191.52
Low
R$191.52
Mkt. cap
55.60B
Avg. vol.
60.00
Volume
61.00
52-wk high
R$213.15
52-wk low
R$143.22
Shares outstanding
62.89M
No. of employees
2K
News stories
From web sources and news partners
bloomingbit
·
33 minutes ago
U.S. Stocks Turn Mixed; Nasdaq Gains 0.95%
ESG Dive
·
14 minutes ago
Corporate boards add fewer new members in 2026: The Conference Board
Yahoo Finance
·
47 minutes ago
Netflix Trades at a Discount to the S&P 500's Valuation. Is It Deserved?
BigGo Finance
·
3 hours ago
Breadth Rebounds Against the Tide as AI Stocks Sell Off; J.P. Morgan Calls for 8,000 by Year-End
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About Argenx Se Bdr